As per the research report, the size of the North America Microbiology Testing/Clinical Microbiology Market is valued at USD 1.57 billion in 2022 and is expected to be growing at a CAGR of 13.12%, to touch USD 2.91 billion by 2027 during the forecast period 2022 to 2027.
The increasing incidence of contagious diseases such as HIV, Hepatitis B and C, human papillomavirus, and some forms of STDs increase the demand for the microbiology testing market.
Microbiology has remained a popular branch of medicine. Microbiology also works to promote health while dealing with clinical applications of bacteria, which is projected to drive the microbiology testing market.
The technological advancements in microbiology ensure significant market growth because various emerging techniques are used for early detection and the effective treatment of pathogen-borne diseases. However, these techniques offer various technological benefits, including better accuracy, faster turnaround time, and increased devices sensitivity compared to traditional laboratory approaches. Furthermore, as end-user preferences change, many notable product manufacturers create and commercialize unique and technologically advanced molecular diagnostic solutions for infectious disease detection.
The initiatives and funds by the government for the development of healthcare infrastructure, such as the establishment of clinical labs, hospitals are some other key factors bolstering the microbiological testing market growth.
Moreover, the recent global pandemic COVID-19 has significantly increased the demand for the microbiology testing market.
Increasing initiatives and funds by the government and non-government organizations in research and development activities and infrastructure development in the region are proving the way for new market entrants.
Other factors such as the availability of the advanced health sector and the critical emerging product manufacturers are propelling the market growth. In addition, the development and commercialization of pathogen-specific reagent/diagnostic kits have resulted in improved sample usage and the adoption of a well-defined clinical technique for specific disease diagnoses.
However, the high cost of equipment used in the microbiology test and the lack of skilled professionals significantly hamper the market growth. In addition, the surge in real-time technological challenges is also impeding market demand. Strict government restrictions for approving new products are also projected to hinder market growth.
This research report on the North America Microbiology Testing/Clinical Microbiology Market has been segmented and sub-segmented into the following categories:
By Microbiology Application:
By Clinical Application:
Geographically, North America dominated the microbiology testing market, and it is most likely to continue its dominance throughout the forecast period. The regional market growth is linked to a well-established healthcare sector, increasing healthcare spending, and favorable reimbursement policies. In addition, the key market players in the region are adopting various market strategies such as mergers and acquisitions are predicted to expand the North American regional market growth.
The U.S microbiology testing market accounted for the largest share of the market, and it is anticipated to register a prominent claim during the forecast period. The U.S witnessed the high penetration of clinical microbiology technologies and significant distribution channels propelling the market growth. Also, manufacturers and industry players focus on research and development activities expected to provide lucrative growth opportunities in the market. In addition, the growing geriatric population, rising awareness about blood-related disorders, and surge in healthcare expenditure are boosting the market growth.
On the other, the Canadian microbiology testing market is projected to witness a promising share during the forecast period. The increasing prevalence of infectious diseases, Supportive government regulations, increasing investments, and funding by the government is contributing to the market growth.
KEY MARKET PLAYERS
Companies playing a dominant role in the North America Microbiology Testing/Clinical Microbiology Market profiled in this report are Danaher Corporation (U.S.), Becton, Dickinson, and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.), among others.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
18.104.22.168 Laboratory Instruments
22.214.171.124 Microbiology Analyzers
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2.4 Food Testing
5.2.6 Chemical and Material Manufacturing
5.2.8 Y-o-Y Growth Analysis, By Application
5.2.9 Market Attractiveness Analysis, By Application
5.2.10 Market Share Analysis, By Application
5.3 Disease Area
5.3.2 Respiratory Disseases
5.3.3 Bloodstream Infections
5.3.4 Gastrointestinal Diseases
5.3.5 Sexually Transmitted Diseases
5.3.6 Urinary Tract Infections
5.3.7 Periodontal Diseases
5.3.9 Y-o-Y Growth Analysis, By Disease Area
5.3.10 Market Attractiveness Analysis, By Disease Area
5.3.11 Market Share Analysis, By Disease Area
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Application
220.127.116.11 By Disease Area
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Application
188.8.131.52 By Disease Area
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By Application
22.214.171.124 By Disease Area
6.2 United States
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Biomerieux S.A.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Danaher Corporation
8.3 Becton, Dickinson and Company
8.4 Cepheid (U.S.)
8.5 Abbott Laboratories, Inc.
8.6 Alere, Inc.
8.7 Bio-Rad Laboratories Inc
8.8 F. Hoffman-LA Roche Ltd.
8.9 Hologic Inc
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.